SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-061663
Filing Date
2022-12-16
Accepted
2022-12-16 16:30:38
Documents
2
Period of Report
2022-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9465
2 POA DOCUMENT poa.txt EX-24 3972
  Complete submission text file 0001209191-22-061663.txt   14812
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SENSEI BIOTHERAPEUTICS, INC. 451 D STREET, SUITE 710 BOSTON MA 02210
Business Address
van der Horst Edward (Reporting) CIK: 0001957499 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39980 | Film No.: 221468346